Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$2.2M
Filings
60
Firms Hired
3
Active Period
1999–2014
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Cancer Drug Coverage Parity Act of 2013
2013 · fourth_quarter · Firm: SUSAN G KOMEN FOR THE CURE ADVOCACY ALLIANCE
Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education, research and clinical trials. (Continued on Addendum)Pub. Law No. 112-25, Budget Control Act of 2011, primarily matters related to funding for cancer prevention and research. Pub. Law No. 113-6, Consolidated and Further Continuing Appropriations Act, 2013, primarily matters related to funding for cancer prevention and research. H.R. 2410, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, primarily matters related to funding for cancer prevention and research. H.R. 1960/S. 1197, National Defense Authorization Act for Fiscal Year 2014, primarily matters related to funding for cancer prevention and research. H.R. 1801, Cancer Drug Coverage Parity Act. S. 1879, Cancer Treatment Parity Act of 2013 H.R. 2477, Planning Actively for Cancer Treatment (PACT) Act of 2013. H.R. 3680, Breast Cancer Awareness Commemorative Coin Act Pub. Law No. 113-54, Drug Quality and Security Act
Client expense: — · Firm income: —
Matched citations: H.R. 1801
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014
2013 · fourth_quarter · Firm: SUSAN G KOMEN FOR THE CURE ADVOCACY ALLIANCE
Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education, research and clinical trials. (Continued on Addendum)Pub. Law No. 112-25, Budget Control Act of 2011, primarily matters related to funding for cancer prevention and research. Pub. Law No. 113-6, Consolidated and Further Continuing Appropriations Act, 2013, primarily matters related to funding for cancer prevention and research. H.R. 2410, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, primarily matters related to funding for cancer prevention and research. H.R. 1960/S. 1197, National Defense Authorization Act for Fiscal Year 2014, primarily matters related to funding for cancer prevention and research. H.R. 1801, Cancer Drug Coverage Parity Act. S. 1879, Cancer Treatment Parity Act of 2013 H.R. 2477, Planning Actively for Cancer Treatment (PACT) Act of 2013. H.R. 3680, Breast Cancer Awareness Commemorative Coin Act Pub. Law No. 113-54, Drug Quality and Security Act
Client expense: — · Firm income: —
Matched citations: H.R. 2410
Planning Actively for Cancer Treatment (PACT) Act of 2013
2013 · fourth_quarter · Firm: SUSAN G KOMEN FOR THE CURE ADVOCACY ALLIANCE
Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education, research and clinical trials. (Continued on Addendum)Pub. Law No. 112-25, Budget Control Act of 2011, primarily matters related to funding for cancer prevention and research. Pub. Law No. 113-6, Consolidated and Further Continuing Appropriations Act, 2013, primarily matters related to funding for cancer prevention and research. H.R. 2410, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, primarily matters related to funding for cancer prevention and research. H.R. 1960/S. 1197, National Defense Authorization Act for Fiscal Year 2014, primarily matters related to funding for cancer prevention and research. H.R. 1801, Cancer Drug Coverage Parity Act. S. 1879, Cancer Treatment Parity Act of 2013 H.R. 2477, Planning Actively for Cancer Treatment (PACT) Act of 2013. H.R. 3680, Breast Cancer Awareness Commemorative Coin Act Pub. Law No. 113-54, Drug Quality and Security Act
Client expense: — · Firm income: —
Matched citations: H.R. 2477
Breast Cancer Awareness Commemorative Coin Act
2013 · fourth_quarter · Firm: SUSAN G KOMEN FOR THE CURE ADVOCACY ALLIANCE
Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education, research and clinical trials. (Continued on Addendum)Pub. Law No. 112-25, Budget Control Act of 2011, primarily matters related to funding for cancer prevention and research. Pub. Law No. 113-6, Consolidated and Further Continuing Appropriations Act, 2013, primarily matters related to funding for cancer prevention and research. H.R. 2410, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, primarily matters related to funding for cancer prevention and research. H.R. 1960/S. 1197, National Defense Authorization Act for Fiscal Year 2014, primarily matters related to funding for cancer prevention and research. H.R. 1801, Cancer Drug Coverage Parity Act. S. 1879, Cancer Treatment Parity Act of 2013 H.R. 2477, Planning Actively for Cancer Treatment (PACT) Act of 2013. H.R. 3680, Breast Cancer Awareness Commemorative Coin Act Pub. Law No. 113-54, Drug Quality and Security Act
Client expense: — · Firm income: —
Matched citations: H.R. 3680
Cancer Treatment Parity Act of 2013
2013 · fourth_quarter · Firm: SUSAN G KOMEN FOR THE CURE ADVOCACY ALLIANCE
Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education, research and clinical trials. (Continued on Addendum)Pub. Law No. 112-25, Budget Control Act of 2011, primarily matters related to funding for cancer prevention and research. Pub. Law No. 113-6, Consolidated and Further Continuing Appropriations Act, 2013, primarily matters related to funding for cancer prevention and research. H.R. 2410, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, primarily matters related to funding for cancer prevention and research. H.R. 1960/S. 1197, National Defense Authorization Act for Fiscal Year 2014, primarily matters related to funding for cancer prevention and research. H.R. 1801, Cancer Drug Coverage Parity Act. S. 1879, Cancer Treatment Parity Act of 2013 H.R. 2477, Planning Actively for Cancer Treatment (PACT) Act of 2013. H.R. 3680, Breast Cancer Awareness Commemorative Coin Act Pub. Law No. 113-54, Drug Quality and Security Act
Client expense: — · Firm income: —
Matched citations: S. 1879
Cancer Patient Protection Act of 2013
2013 · third_quarter · Firm: SUSAN G KOMEN FOR THE CURE ADVOCACY ALLIANCE
Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education, research and clinical trials. (Continued on Addendum)Pub. Law No. 112-25, Budget Control Act of 2011, primarily matters related to funding for cancer prevention and research. Pub. Law No. 113-6, Consolidated and Further Continuing Appropriations Act, 2013, primarily matters related to funding for cancer prevention and research. H.R. 2410, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, primarily matters related to funding for cancer prevention and research. H.R. 1960/S. 1197, National Defense Authorization Act for Fiscal Year 2014, primarily matters related to funding for cancer prevention and research. H.R. 1416, Cancer Patient Protection Act of 2013. H.R. 1531/S.931, Support of the Breast Cancer Patient Protection Act of 2013. H.R. 1801, Cancer Drug Coverage Parity Act. H.R. 1984, Breast Cancer Patient Education Act of 2013. H.R. 2477, Planning Actively for Cancer Treatment (PACT) Act of 2013. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. H.R. 3204, Drug Quality and Security Act S. 957, Drug Supply Chain Security Act.
Client expense: $20,000 · Firm income: —
Matched citations: H.R. 1416
Breast Cancer Patient Protection Act of 2013
2013 · third_quarter · Firm: SUSAN G KOMEN FOR THE CURE ADVOCACY ALLIANCE
Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education, research and clinical trials. (Continued on Addendum)Pub. Law No. 112-25, Budget Control Act of 2011, primarily matters related to funding for cancer prevention and research. Pub. Law No. 113-6, Consolidated and Further Continuing Appropriations Act, 2013, primarily matters related to funding for cancer prevention and research. H.R. 2410, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, primarily matters related to funding for cancer prevention and research. H.R. 1960/S. 1197, National Defense Authorization Act for Fiscal Year 2014, primarily matters related to funding for cancer prevention and research. H.R. 1416, Cancer Patient Protection Act of 2013. H.R. 1531/S.931, Support of the Breast Cancer Patient Protection Act of 2013. H.R. 1801, Cancer Drug Coverage Parity Act. H.R. 1984, Breast Cancer Patient Education Act of 2013. H.R. 2477, Planning Actively for Cancer Treatment (PACT) Act of 2013. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. H.R. 3204, Drug Quality and Security Act S. 957, Drug Supply Chain Security Act.
Client expense: $20,000 · Firm income: —
Matched citations: H.R. 1531
Cancer Drug Coverage Parity Act of 2013
2013 · third_quarter · Firm: SUSAN G KOMEN FOR THE CURE ADVOCACY ALLIANCE
Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education, research and clinical trials. (Continued on Addendum)Pub. Law No. 112-25, Budget Control Act of 2011, primarily matters related to funding for cancer prevention and research. Pub. Law No. 113-6, Consolidated and Further Continuing Appropriations Act, 2013, primarily matters related to funding for cancer prevention and research. H.R. 2410, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, primarily matters related to funding for cancer prevention and research. H.R. 1960/S. 1197, National Defense Authorization Act for Fiscal Year 2014, primarily matters related to funding for cancer prevention and research. H.R. 1416, Cancer Patient Protection Act of 2013. H.R. 1531/S.931, Support of the Breast Cancer Patient Protection Act of 2013. H.R. 1801, Cancer Drug Coverage Parity Act. H.R. 1984, Breast Cancer Patient Education Act of 2013. H.R. 2477, Planning Actively for Cancer Treatment (PACT) Act of 2013. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. H.R. 3204, Drug Quality and Security Act S. 957, Drug Supply Chain Security Act.
Client expense: $20,000 · Firm income: —
Matched citations: H.R. 1801
Safeguarding America's Pharmaceuticals Act of 2013
2013 · third_quarter · Firm: SUSAN G KOMEN FOR THE CURE ADVOCACY ALLIANCE
Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education, research and clinical trials. (Continued on Addendum)Pub. Law No. 112-25, Budget Control Act of 2011, primarily matters related to funding for cancer prevention and research. Pub. Law No. 113-6, Consolidated and Further Continuing Appropriations Act, 2013, primarily matters related to funding for cancer prevention and research. H.R. 2410, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, primarily matters related to funding for cancer prevention and research. H.R. 1960/S. 1197, National Defense Authorization Act for Fiscal Year 2014, primarily matters related to funding for cancer prevention and research. H.R. 1416, Cancer Patient Protection Act of 2013. H.R. 1531/S.931, Support of the Breast Cancer Patient Protection Act of 2013. H.R. 1801, Cancer Drug Coverage Parity Act. H.R. 1984, Breast Cancer Patient Education Act of 2013. H.R. 2477, Planning Actively for Cancer Treatment (PACT) Act of 2013. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. H.R. 3204, Drug Quality and Security Act S. 957, Drug Supply Chain Security Act.
Client expense: $20,000 · Firm income: —
Matched citations: H.R. 1919
Breast Cancer Patient Education Act of 2013
2013 · third_quarter · Firm: SUSAN G KOMEN FOR THE CURE ADVOCACY ALLIANCE
Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education, research and clinical trials. (Continued on Addendum)Pub. Law No. 112-25, Budget Control Act of 2011, primarily matters related to funding for cancer prevention and research. Pub. Law No. 113-6, Consolidated and Further Continuing Appropriations Act, 2013, primarily matters related to funding for cancer prevention and research. H.R. 2410, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, primarily matters related to funding for cancer prevention and research. H.R. 1960/S. 1197, National Defense Authorization Act for Fiscal Year 2014, primarily matters related to funding for cancer prevention and research. H.R. 1416, Cancer Patient Protection Act of 2013. H.R. 1531/S.931, Support of the Breast Cancer Patient Protection Act of 2013. H.R. 1801, Cancer Drug Coverage Parity Act. H.R. 1984, Breast Cancer Patient Education Act of 2013. H.R. 2477, Planning Actively for Cancer Treatment (PACT) Act of 2013. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. H.R. 3204, Drug Quality and Security Act S. 957, Drug Supply Chain Security Act.
Client expense: $20,000 · Firm income: —
Matched citations: H.R. 1984
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014
2013 · third_quarter · Firm: SUSAN G KOMEN FOR THE CURE ADVOCACY ALLIANCE
Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education, research and clinical trials. (Continued on Addendum)Pub. Law No. 112-25, Budget Control Act of 2011, primarily matters related to funding for cancer prevention and research. Pub. Law No. 113-6, Consolidated and Further Continuing Appropriations Act, 2013, primarily matters related to funding for cancer prevention and research. H.R. 2410, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, primarily matters related to funding for cancer prevention and research. H.R. 1960/S. 1197, National Defense Authorization Act for Fiscal Year 2014, primarily matters related to funding for cancer prevention and research. H.R. 1416, Cancer Patient Protection Act of 2013. H.R. 1531/S.931, Support of the Breast Cancer Patient Protection Act of 2013. H.R. 1801, Cancer Drug Coverage Parity Act. H.R. 1984, Breast Cancer Patient Education Act of 2013. H.R. 2477, Planning Actively for Cancer Treatment (PACT) Act of 2013. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. H.R. 3204, Drug Quality and Security Act S. 957, Drug Supply Chain Security Act.
Client expense: $20,000 · Firm income: —
Matched citations: H.R. 2410
Planning Actively for Cancer Treatment (PACT) Act of 2013
2013 · third_quarter · Firm: SUSAN G KOMEN FOR THE CURE ADVOCACY ALLIANCE
Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education, research and clinical trials. (Continued on Addendum)Pub. Law No. 112-25, Budget Control Act of 2011, primarily matters related to funding for cancer prevention and research. Pub. Law No. 113-6, Consolidated and Further Continuing Appropriations Act, 2013, primarily matters related to funding for cancer prevention and research. H.R. 2410, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, primarily matters related to funding for cancer prevention and research. H.R. 1960/S. 1197, National Defense Authorization Act for Fiscal Year 2014, primarily matters related to funding for cancer prevention and research. H.R. 1416, Cancer Patient Protection Act of 2013. H.R. 1531/S.931, Support of the Breast Cancer Patient Protection Act of 2013. H.R. 1801, Cancer Drug Coverage Parity Act. H.R. 1984, Breast Cancer Patient Education Act of 2013. H.R. 2477, Planning Actively for Cancer Treatment (PACT) Act of 2013. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. H.R. 3204, Drug Quality and Security Act S. 957, Drug Supply Chain Security Act.
Client expense: $20,000 · Firm income: —
Matched citations: H.R. 2477
Drug Quality and Security Act
2013 · third_quarter · Firm: SUSAN G KOMEN FOR THE CURE ADVOCACY ALLIANCE
Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education, research and clinical trials. (Continued on Addendum)Pub. Law No. 112-25, Budget Control Act of 2011, primarily matters related to funding for cancer prevention and research. Pub. Law No. 113-6, Consolidated and Further Continuing Appropriations Act, 2013, primarily matters related to funding for cancer prevention and research. H.R. 2410, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, primarily matters related to funding for cancer prevention and research. H.R. 1960/S. 1197, National Defense Authorization Act for Fiscal Year 2014, primarily matters related to funding for cancer prevention and research. H.R. 1416, Cancer Patient Protection Act of 2013. H.R. 1531/S.931, Support of the Breast Cancer Patient Protection Act of 2013. H.R. 1801, Cancer Drug Coverage Parity Act. H.R. 1984, Breast Cancer Patient Education Act of 2013. H.R. 2477, Planning Actively for Cancer Treatment (PACT) Act of 2013. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. H.R. 3204, Drug Quality and Security Act S. 957, Drug Supply Chain Security Act.
Client expense: $20,000 · Firm income: —
Matched citations: H.R. 3204
Breast Cancer Patient Education Act of 2013
2013 · third_quarter · Firm: SUSAN G KOMEN FOR THE CURE ADVOCACY ALLIANCE
Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education, research and clinical trials. (Continued on Addendum)Pub. Law No. 112-25, Budget Control Act of 2011, primarily matters related to funding for cancer prevention and research. Pub. Law No. 113-6, Consolidated and Further Continuing Appropriations Act, 2013, primarily matters related to funding for cancer prevention and research. H.R. 2410, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, primarily matters related to funding for cancer prevention and research. H.R. 1960/S. 1197, National Defense Authorization Act for Fiscal Year 2014, primarily matters related to funding for cancer prevention and research. H.R. 1416, Cancer Patient Protection Act of 2013. H.R. 1531/S.931, Support of the Breast Cancer Patient Protection Act of 2013. H.R. 1801, Cancer Drug Coverage Parity Act. H.R. 1984, Breast Cancer Patient Education Act of 2013. H.R. 2477, Planning Actively for Cancer Treatment (PACT) Act of 2013. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. H.R. 3204, Drug Quality and Security Act S. 957, Drug Supply Chain Security Act.
Client expense: $20,000 · Firm income: —
Matched citations: S.931
Drug Supply Chain Security Act
2013 · third_quarter · Firm: SUSAN G KOMEN FOR THE CURE ADVOCACY ALLIANCE
Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education, research and clinical trials. (Continued on Addendum)Pub. Law No. 112-25, Budget Control Act of 2011, primarily matters related to funding for cancer prevention and research. Pub. Law No. 113-6, Consolidated and Further Continuing Appropriations Act, 2013, primarily matters related to funding for cancer prevention and research. H.R. 2410, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, primarily matters related to funding for cancer prevention and research. H.R. 1960/S. 1197, National Defense Authorization Act for Fiscal Year 2014, primarily matters related to funding for cancer prevention and research. H.R. 1416, Cancer Patient Protection Act of 2013. H.R. 1531/S.931, Support of the Breast Cancer Patient Protection Act of 2013. H.R. 1801, Cancer Drug Coverage Parity Act. H.R. 1984, Breast Cancer Patient Education Act of 2013. H.R. 2477, Planning Actively for Cancer Treatment (PACT) Act of 2013. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. H.R. 3204, Drug Quality and Security Act S. 957, Drug Supply Chain Security Act.
Client expense: $20,000 · Firm income: —
Matched citations: S. 957
Cancer Patient Protection Act of 2013
2013 · second_quarter · Firm: SUSAN G KOMEN FOR THE CURE ADVOCACY ALLIANCE
Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education, research and clinical trials. (Continued on Addendum)Pub. Law No. 112-25, Budget Control Act of 2011, primarily matters related to funding for cancer prevention and research. Pub. Law No. 113-6, Consolidated and Further Continuing Appropriations Act, 2013, primarily matters related to funding for cancer prevention and research. H.R. 2410, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, primarily matters related to funding for cancer prevention and research. H.R. 1960/S. 1197, National Defense Authorization Act for Fiscal Year 2014, primarily matters related to funding for cancer prevention and research. H.R. 1416, Cancer Patient Protection Act of 2013. H.R. 1531/S.931, Support of the Breast Cancer Patient Protection Act of 2013. H.R. 1801, Cancer Drug Coverage Parity Act. H.R. 1984, Breast Cancer Patient Education Act of 2013. H.R. 2477, Planning Actively for Cancer Treatment (PACT) Act of 2013. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. S. 957, Drug Supply Chain Security Act.
Client expense: $10,000 · Firm income: —
Matched citations: H.R. 1416
Breast Cancer Patient Protection Act of 2013
2013 · second_quarter · Firm: SUSAN G KOMEN FOR THE CURE ADVOCACY ALLIANCE
Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education, research and clinical trials. (Continued on Addendum)Pub. Law No. 112-25, Budget Control Act of 2011, primarily matters related to funding for cancer prevention and research. Pub. Law No. 113-6, Consolidated and Further Continuing Appropriations Act, 2013, primarily matters related to funding for cancer prevention and research. H.R. 2410, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, primarily matters related to funding for cancer prevention and research. H.R. 1960/S. 1197, National Defense Authorization Act for Fiscal Year 2014, primarily matters related to funding for cancer prevention and research. H.R. 1416, Cancer Patient Protection Act of 2013. H.R. 1531/S.931, Support of the Breast Cancer Patient Protection Act of 2013. H.R. 1801, Cancer Drug Coverage Parity Act. H.R. 1984, Breast Cancer Patient Education Act of 2013. H.R. 2477, Planning Actively for Cancer Treatment (PACT) Act of 2013. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. S. 957, Drug Supply Chain Security Act.
Client expense: $10,000 · Firm income: —
Matched citations: H.R. 1531
Cancer Drug Coverage Parity Act of 2013
2013 · second_quarter · Firm: SUSAN G KOMEN FOR THE CURE ADVOCACY ALLIANCE
Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education, research and clinical trials. (Continued on Addendum)Pub. Law No. 112-25, Budget Control Act of 2011, primarily matters related to funding for cancer prevention and research. Pub. Law No. 113-6, Consolidated and Further Continuing Appropriations Act, 2013, primarily matters related to funding for cancer prevention and research. H.R. 2410, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, primarily matters related to funding for cancer prevention and research. H.R. 1960/S. 1197, National Defense Authorization Act for Fiscal Year 2014, primarily matters related to funding for cancer prevention and research. H.R. 1416, Cancer Patient Protection Act of 2013. H.R. 1531/S.931, Support of the Breast Cancer Patient Protection Act of 2013. H.R. 1801, Cancer Drug Coverage Parity Act. H.R. 1984, Breast Cancer Patient Education Act of 2013. H.R. 2477, Planning Actively for Cancer Treatment (PACT) Act of 2013. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. S. 957, Drug Supply Chain Security Act.
Client expense: $10,000 · Firm income: —
Matched citations: H.R. 1801
Safeguarding America's Pharmaceuticals Act of 2013
2013 · second_quarter · Firm: SUSAN G KOMEN FOR THE CURE ADVOCACY ALLIANCE
Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education, research and clinical trials. (Continued on Addendum)Pub. Law No. 112-25, Budget Control Act of 2011, primarily matters related to funding for cancer prevention and research. Pub. Law No. 113-6, Consolidated and Further Continuing Appropriations Act, 2013, primarily matters related to funding for cancer prevention and research. H.R. 2410, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, primarily matters related to funding for cancer prevention and research. H.R. 1960/S. 1197, National Defense Authorization Act for Fiscal Year 2014, primarily matters related to funding for cancer prevention and research. H.R. 1416, Cancer Patient Protection Act of 2013. H.R. 1531/S.931, Support of the Breast Cancer Patient Protection Act of 2013. H.R. 1801, Cancer Drug Coverage Parity Act. H.R. 1984, Breast Cancer Patient Education Act of 2013. H.R. 2477, Planning Actively for Cancer Treatment (PACT) Act of 2013. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. S. 957, Drug Supply Chain Security Act.
Client expense: $10,000 · Firm income: —
Matched citations: H.R. 1919
Breast Cancer Patient Education Act of 2013
2013 · second_quarter · Firm: SUSAN G KOMEN FOR THE CURE ADVOCACY ALLIANCE
Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education, research and clinical trials. (Continued on Addendum)Pub. Law No. 112-25, Budget Control Act of 2011, primarily matters related to funding for cancer prevention and research. Pub. Law No. 113-6, Consolidated and Further Continuing Appropriations Act, 2013, primarily matters related to funding for cancer prevention and research. H.R. 2410, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, primarily matters related to funding for cancer prevention and research. H.R. 1960/S. 1197, National Defense Authorization Act for Fiscal Year 2014, primarily matters related to funding for cancer prevention and research. H.R. 1416, Cancer Patient Protection Act of 2013. H.R. 1531/S.931, Support of the Breast Cancer Patient Protection Act of 2013. H.R. 1801, Cancer Drug Coverage Parity Act. H.R. 1984, Breast Cancer Patient Education Act of 2013. H.R. 2477, Planning Actively for Cancer Treatment (PACT) Act of 2013. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. S. 957, Drug Supply Chain Security Act.
Client expense: $10,000 · Firm income: —
Matched citations: H.R. 1984
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014
2013 · second_quarter · Firm: SUSAN G KOMEN FOR THE CURE ADVOCACY ALLIANCE
Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education, research and clinical trials. (Continued on Addendum)Pub. Law No. 112-25, Budget Control Act of 2011, primarily matters related to funding for cancer prevention and research. Pub. Law No. 113-6, Consolidated and Further Continuing Appropriations Act, 2013, primarily matters related to funding for cancer prevention and research. H.R. 2410, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, primarily matters related to funding for cancer prevention and research. H.R. 1960/S. 1197, National Defense Authorization Act for Fiscal Year 2014, primarily matters related to funding for cancer prevention and research. H.R. 1416, Cancer Patient Protection Act of 2013. H.R. 1531/S.931, Support of the Breast Cancer Patient Protection Act of 2013. H.R. 1801, Cancer Drug Coverage Parity Act. H.R. 1984, Breast Cancer Patient Education Act of 2013. H.R. 2477, Planning Actively for Cancer Treatment (PACT) Act of 2013. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. S. 957, Drug Supply Chain Security Act.
Client expense: $10,000 · Firm income: —
Matched citations: H.R. 2410
Planning Actively for Cancer Treatment (PACT) Act of 2013
2013 · second_quarter · Firm: SUSAN G KOMEN FOR THE CURE ADVOCACY ALLIANCE
Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education, research and clinical trials. (Continued on Addendum)Pub. Law No. 112-25, Budget Control Act of 2011, primarily matters related to funding for cancer prevention and research. Pub. Law No. 113-6, Consolidated and Further Continuing Appropriations Act, 2013, primarily matters related to funding for cancer prevention and research. H.R. 2410, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, primarily matters related to funding for cancer prevention and research. H.R. 1960/S. 1197, National Defense Authorization Act for Fiscal Year 2014, primarily matters related to funding for cancer prevention and research. H.R. 1416, Cancer Patient Protection Act of 2013. H.R. 1531/S.931, Support of the Breast Cancer Patient Protection Act of 2013. H.R. 1801, Cancer Drug Coverage Parity Act. H.R. 1984, Breast Cancer Patient Education Act of 2013. H.R. 2477, Planning Actively for Cancer Treatment (PACT) Act of 2013. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. S. 957, Drug Supply Chain Security Act.
Client expense: $10,000 · Firm income: —
Matched citations: H.R. 2477
Breast Cancer Patient Education Act of 2013
2013 · second_quarter · Firm: SUSAN G KOMEN FOR THE CURE ADVOCACY ALLIANCE
Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education, research and clinical trials. (Continued on Addendum)Pub. Law No. 112-25, Budget Control Act of 2011, primarily matters related to funding for cancer prevention and research. Pub. Law No. 113-6, Consolidated and Further Continuing Appropriations Act, 2013, primarily matters related to funding for cancer prevention and research. H.R. 2410, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, primarily matters related to funding for cancer prevention and research. H.R. 1960/S. 1197, National Defense Authorization Act for Fiscal Year 2014, primarily matters related to funding for cancer prevention and research. H.R. 1416, Cancer Patient Protection Act of 2013. H.R. 1531/S.931, Support of the Breast Cancer Patient Protection Act of 2013. H.R. 1801, Cancer Drug Coverage Parity Act. H.R. 1984, Breast Cancer Patient Education Act of 2013. H.R. 2477, Planning Actively for Cancer Treatment (PACT) Act of 2013. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. S. 957, Drug Supply Chain Security Act.
Client expense: $10,000 · Firm income: —
Matched citations: S.931
Drug Supply Chain Security Act
2013 · second_quarter · Firm: SUSAN G KOMEN FOR THE CURE ADVOCACY ALLIANCE
Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education, research and clinical trials. (Continued on Addendum)Pub. Law No. 112-25, Budget Control Act of 2011, primarily matters related to funding for cancer prevention and research. Pub. Law No. 113-6, Consolidated and Further Continuing Appropriations Act, 2013, primarily matters related to funding for cancer prevention and research. H.R. 2410, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, primarily matters related to funding for cancer prevention and research. H.R. 1960/S. 1197, National Defense Authorization Act for Fiscal Year 2014, primarily matters related to funding for cancer prevention and research. H.R. 1416, Cancer Patient Protection Act of 2013. H.R. 1531/S.931, Support of the Breast Cancer Patient Protection Act of 2013. H.R. 1801, Cancer Drug Coverage Parity Act. H.R. 1984, Breast Cancer Patient Education Act of 2013. H.R. 2477, Planning Actively for Cancer Treatment (PACT) Act of 2013. H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013. S. 957, Drug Supply Chain Security Act.
Client expense: $10,000 · Firm income: —
Matched citations: S. 957
Drug Safety Enhancement Act of 2011
2012 · fourth_quarter · Firm: SUSAN G KOMEN FOR THE CURE ADVOCACY ALLIANCE
Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education, research and clinical trials. (Continued on Addendum) H.R.2245/S.296, Preserving Access to Life-Saving Medications Act of 2011, primarily matters related to establishing notification requirements to mitigate drug shortages. H.R. 3839, Drug Shortage Prevention Act of 2012. H.R.2499, Lymphedema Diagnosis and Treatment Cost-Saving Act of 2011. H.R.3102, Breast Density and Mammography Reporting Act of 2011. H.R.3705, Comprehensive Cancer Care Improvement Act of 2011. H.R.2746, Cancer Drug Coverage Parity Act of 2011. H.R.1483, Drug Safety Enhancement Act of 2011, primarily matters related to ensuring the safety and quality of the drug supply chain. H.R.3699, Research Works Act, primarily matters related to opposing it in order to protect the NIH Public Access Policy. S.2113, Transforming the Regulatory Environment to Accelerate Access to Treatments, primarily matters related to codifying and clarifying FDA authority to expedite approval of new treatments for life-threatening conditions. S.2236, Advancing Breakthrough Therapies for Patients Act of 2012. Pub. Law No. 112-144, Food and Drug Administration Safety and Innovation Act of 2012, primarily matters related to drug shortages, drug approval and patient access. H.R. 4209, Patients' Access to Treatments Act of 2012. H.R. 5937, Breast Cancer Patient Education Act of 2012. Pub. Law No. 112-240, American Taxpayer Relief Act of 2012, primarily matters related to funding for the National Breast and Cervical Cancer Early Detection Program and the National Institutes of Health.
Client expense: $30,000 · Firm income: —
Matched citations: H.R.1483
Source: Senate LDA